China Health Holding Announces Acquisition of Henan Furen Huaiqingtang Pharmaceuticals Co. Ltd., PR China.BEIJING -- China Health Holding (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CHHH), a developer, marketer and manufacturer of natural herbal herbal, early botanical book containing descriptions and illustrations of herbs and plants with their properties, chiefly those qualities that made them useful as medicines or condiments. Most of the herbals were written between c.1470 and c. supplement products based on traditional Chinese medicine Traditional Chinese Medicine Definition Traditional Chinese medicine (TCM) is an ancient and still very vital holistic system of health and healing, based on the notion of harmony and balance, and employing the ideas of moderation and prevention. , Julianna Lu, the President/CEO, announced today that the Company entered into a Letter of Intent with Furen Pharmaceuticals Group Co., Ltd, PR China for the proposed acquisition by the Company of 51% or more of Henan Furen Huaiqingtang Pharmaceuticals Co. Ltd., PR China, the wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Furen Pharmaceuticals Group Co., Ltd. Pursuant to the letter of intent, the parties have expressed their intent and support for the cooperation and accomplishment of the acquisition of Henan Furen Huaiqingtang Pharmaceuticals Co. Ltd. by the Company. Further, Furen Pharmaceuticals Group Co., Ltd has agreed to offer the Company with first refusal rights and legal exclusive rights for the acquisition of 51% or more of Henan Furen Huaiqingtang Pharmaceuticals Co. Ltd. in the next nine months from the date of the signed Letter of Intent. The completion of the acquisition is subject to the negotiation and execution of a definitive acquisition agreement, as well as the completion of full legal and financial due diligence Research; analysis; your homework. This term has caught on in all industries, because it sounds so "wired." Who would want to do analysis or research when they can do due diligence. See wired. , including the determination of the valuation of Henan Furen Huaiqingtang Pharmaceuticals Co. Ltd. and the delivery of audited financial statements of Henan Furen Huaiqingtang Pharmaceuticals Co. Ltd. The Company believes that further acquisition will enable the Company to vertically integrate its operations from manufacturing and developing and marketing Chinese herbal based medicinal products medicinal product, n a substance administered to humans or animals through injection, application, oral ingestion, inhalation, and so forth, whose purpose is to ultimately restore health or eliminate disease in an individual. , as well as pharmaceutical drugs pipeline to fully distribution and marketing across P.R. China, therefore substantially increasing profit margins. The acquisition should accelerate growth of our revenues and earnings for years to come. The acquisition contemplated by the Letter of Intent with Furen Pharmaceuticals Group Co., Ltd. is part of the Company's comprehensive growth strategy. The Company believes that its strategy of pursuing the strategic combination of assets and net income and unique enhanced pharmaceutical drug pipeline and technologies will accrete value to the Company and its shareholders. The Company also believes that its acquisition growth strategy will assist the Company in securing a strong future and powerful position in the global and China medical and pharmaceutical industry. About China Health Holding, Inc. (Updated) China Health Holding, Inc., with an extensive knowledge of and expertise in the field of Traditional Chinese Medicine, develops, manufactures, and commercializes natural herbal medicinal products and a comprehensive line of completely natural multi-vitamins and mineral food supplements. The company's medicinal medicinal /me·dic·i·nal/ (mi-dis´in-il) having healing qualities; pertaining to a medicine. me·dic·i·nal adj. Of, relating to, or having the properties of medicine. philosophy includes elements of traditional Taoist teachings and medical research related to the "King of Herbs" and significant herbal plants and minerals. China Health Holding's immediate goal is profitable penetration of the growing global market for natural herbal medicinal remedies and health enhancement products. The long-term plans include the development of pharmaceutical drug pipeline and technologies based on the company's access to the knowledge of Traditional Chinese Medicine and PR China Pharmaceutical Industry. The company's immediately comprehensive plan to seek and develop potential merger and acquisition candidates with major pharmaceutical companies in PR china and worldwide in securing a strong future and powerful position in the global and PR China pharmaceutical industry. The company is supported by two core, wholly owned subsidiaries: --China Health World Pharmaceutical Corporation develops, manufactures and commercializes natural medications for epidemic diseases Noun 1. epidemic disease - any infectious disease that develops and spreads rapidly to many people pest, pestilence, plague - any epidemic disease with a high death rate infectious disease - a disease transmitted only by a specific kind of contact and conditions related to mellitus, cardiovascular cardiovascular /car·dio·vas·cu·lar/ (-vas´ku-ler) pertaining to the heart and blood vessels. car·di·o·vas·cu·lar adj. Abbr. and cerebral-vascular system dysfunctions, and neurological disorders This is a list of major and frequently observed neurological disorders (e.g. Alzheimer's disease), symptoms (e.g.back pain), signs (e.g. aphasia) and syndromes (e.g. Aicardi syndrome). . --China Health World Trade Corporation supports CHHH in the areas of worldwide branding, multimedia marketing and multi-channel distribution to global customers and markets. Recent Developments China Health Holding recently entered into Acquisition Letters of Intent to acquire 51% or more of four pharmaceutical companies in PR China: -- Shaanxi Wanan Pharmaceutical Co. Ltd., -- Henan Tiankang Pharmaceuticals Co. Ltd., and -- Henan Furen Huaiqingtang Pharmaceuticals Co. Ltd. -- Shannxi Meichen Pharmaceutical Co. Ltd. The company also recently signed a Letter of Intent with WangJing Hospital and the WangJing Hospital of China Academy of Chinese Medical Sciences, PR China, in order to develop the China International University of Traditional Chinese Medicine and the University Hospital for Traditional Chinese Medical Sciences. Please visit www.chinahealthholding.com for the company's profile. Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. To the extent that statements in the press releases are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives,future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, All forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. , whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K Form 8-K The form required by the SEC when a publicly held company incurs any event that might affect its financial situation or the share value of its stock. Form 8-K See 8-K. . In addition, the company disclaims any obligation to update or correct any forward-looking statements in all the Company's press releases to reflect events or circumstances CIRCUMSTANCES, evidence. The particulars which accompany a fact. 2. The facts proved are either possible or impossible, ordinary and probable, or extraordinary and improbable, recent or ancient; they may have happened near us, or afar off; they are public or after the date hereof here·of adv. Of this. hereof Adverb Formal or law of or concerning this Adv. 1. hereof - of or concerning this; "the twigs hereof are physic" . |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion